Prime Medicine, Inc. Common Stock Income Statement
Concept
Total Revenue
YoY
Cost of Goods Sold (COGS)
Gross Profit
Operating expenses
Selling, General & Administrative
Research & Development
Operating Income
Interest Expense
Income Before Tax
Tax Provision
Net Income
YoY
Total Expenses
Net Interest Income
EBITDA
Reconciled Depreciation
EBIT
2023
2022
2021
2020
2019
0M
-100.00%
5M
-5M
187M
43M
148M
-191M
0M
-198M
0M
-198M
62.64%
191M
0M
-187M
4M
-191M
5M
-
12M
-7M
117M
30M
87M
-117M
12M
-123M
-1M
-122M
-26.33%
117M
0M
-108M
2M
-117M
0M
-100.00%
5M
-5M
84M
14M
71M
-84M
82M
-166M
0M
-165M
4,749.47%
84M
0M
-84M
1M
-84M
5M
-
0M
5M
6M
3M
3M
-1M
10M
-2M
2M
-3M
34.84%
6M
0M
-12M
0M
-1M
0M
-
0M
0M
2M
0M
1M
-2M
0M
-3M
0M
-3M
34.84%
2M
0M
-2M
0M
-2M
Concept
Total Revenue
YoY
Cost of Goods Sold (COGS)
Gross Profit
Operating expenses
Selling, General & Administrative
Research & Development
Operating Income
Interest Expense
Income Before Tax
Tax Provision
Net Income
YoY
Total Expenses
Net Interest Income
EBITDA
Reconciled Depreciation
EBIT
4Q2023
3Q2023
2Q2023
1Q2023
4Q2022
3Q2022
2Q2022
1Q2022
4Q2021
3Q2021
2Q2021
4Q2019
0M
-100.00%
1M
-1M
53M
13M
41M
-55M
0M
-66M
0M
-66M
67.10%
55M
0M
-53M
1M
-55M
0M
-
4M
-4M
51M
10M
41M
-51M
0M
-51M
0M
-51M
72.77%
51M
0M
-49M
1M
-50M
0M
-
5M
-5M
45M
11M
35M
-45M
0M
-42M
0M
-42M
44.42%
45M
0M
-46M
1M
-47M
0M
-
4M
-4M
40M
9M
31M
-40M
0M
-40M
0M
-39M
65.26%
40M
0M
-38M
1M
-40M
5M
-
4M
2M
39M
10M
29M
-39M
2M
-39M
0M
-39M
-37.56%
39M
0M
-37M
1M
-39M
0M
-
3M
-3M
32M
7M
25M
-32M
4M
-29M
0M
-29M
78.83%
32M
0M
-33M
1M
-32M
0M
-
0M
0M
26M
7M
19M
-26M
7M
-30M
0M
-29M
78.83%
26M
0M
-22M
0M
-23M
0M
-
0M
0M
20M
6M
14M
-20M
9M
-24M
-1M
-24M
842.67%
20M
0M
-15M
0M
-15M
0M
-
0M
0M
60M
7M
53M
-60M
0M
-62M
1M
-63M
842.67%
60M
0M
-58M
0M
-59M
0M
-
0M
0M
10M
3M
7M
-10M
0M
-19M
-2M
-16M
842.67%
10M
0M
-2M
0M
-2M
0M
-
0M
0M
0M
0M
0M
0M
0M
0M
0M
0M
842.67%
0M
0M
0M
0M
-8M
0M
-
0M
0M
2M
1M
1M
-2M
0M
-3M
0M
-3M
842.67%
2M
0M
-3M
0M
-2M